ESPE Abstracts

Objective: To identify factors influencing compliance with daily recombinant growth hormone (rhGH) therapy in children and adolescents with growth hormone deficiency (GHD) and born as small for gestational age (SGA) based on data from two European paediatric endocrinology centres.Study population and methods: The study population included 130 patients with GHD or SGA from Szczecin (Poland) and Messina (Italy); 53% of pat...

Aim: To identify factors affecting compliance to treatment with recombinant growth hormone (rhGH) in children with growth hormone deficiency (GHD).Study population and Methods: The following data were collected during standard visits in 8 endocrine clinics in Poland: medical history, auxological measurements, laboratory tests and the numbers of empty and full rhGH ampoules dispensed and returned by the patients. The obse...

Objective: The aim of this study was to assess the compliance with recombinant growth hormone (rhGH) therapy in children diagnosed with growth hormone deficiency (GHD) and identify the factors that may influence compliance.Study Population and Methods: This multicentre study was conducted in 12 endocrine clinics in Poland. During routine visits, medical history, auxological measurements, laboratory tests, and the quantit...